Skip to main content
/
AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
23.70
+2.56 (12.11%)
At close: Jun 6, 2025, 4:00 PM
24.50
+0.80 (3.38%)
After-hours: Jun 6, 2025, 6:34 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024FY 2023FY 2022FY 2021FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
GSK - Royalty - Jemperli
47.38M
Log In
Log In
Log In
Log In
Upgrade
GSK -Milestones
40.00M
Log In
Log In
Log In
Log In
Upgrade
GSK -Milestones Growth
-
Log In
Log In
Log In
Log In
Upgrade
GSK - Royalty - Zejula
3.90M
Log In
Log In
Log In
Log In
Upgrade
GSK - Royalty
-
Log In
Log In
Log In
Log In
Upgrade
GSK - Royalty Growth
-
Log In
Log In
Log In
Log In
Upgrade
GSK - Amendment
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024FY 2023FY 2022FY 2021FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States and Australia
91.28M
Log In
Log In
Log In
Log In
Upgrade
United States and Australia Growth
432.03%
Log In
Log In
Log In
Log In
Upgrade